The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 264 | 256 | 259 | 296 |
| Depreciation and amortization | 147 | 145 | 142 | 143 |
| Provision for credit losses | 1 | 1 | 0 | 1 |
| Deferred income tax expense | 48 | -13 | 110 | 1 |
| Stock-based compensation expense | 20 | 25 | 20 | 21 |
| Other, net | -8 | 13 | -11 | -27 |
| Accounts receivable | 180 | -47 | 38 | 14 |
| Accounts payable and accrued expenses | -12 | 16 | 124 | 42 |
| Income taxes payable | 13 | 25 | -10 | -6 |
| Other assets and liabilities, net | 31 | 24 | 55 | -33 |
| Net cash provided by operating activities | 278 | 465 | 563 | 544 |
| Business acquisitions, net of cash acquired | 38 | 50 | 34 | 17 |
| Capital expenditures | 114 | 158 | 144 | 108 |
| Other investing activities, net | 0 | -17 | 23 | -1 |
| Net cash used in investing activities | -152 | -191 | -201 | -124 |
| Proceeds from borrowings | 0 | 0 | 10 | 185 |
| Repayments of debt | 1 | 1 | 10 | 401 |
| Purchases of treasury stock | - | 300 | 150 | - |
| Exercise of stock options | 65 | 18 | 19 | 13 |
| Employee payroll tax withholdings on stock issued under stock-based compensation plans | 37 | 1 | 2 | 0 |
| Dividends paid | 88 | 90 | 89 | 90 |
| Distributions to noncontrolling interest partners | 7 | 13 | 14 | 11 |
| Other financing activities, net | -84 | 100 | -11 | 11 |
| Net cash used in financing activities | -152 | -287 | -247 | -293 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | -1 | 1 | -2 | 4 |
| Net change in cash and cash equivalents and restricted cash | -27 | -12 | 113 | 131 |
| Cash and cash equivalents and restricted cash, beginning of period | 420 | 432 | 319 | 188 |
| Cash and cash equivalents and restricted cash, end of period | 393 | 420 | 432 | 319 |
QUEST DIAGNOSTICS INC (DGX)
QUEST DIAGNOSTICS INC (DGX)